Xylometazoline is an alpha-adrenergic agonist that causes vasoconstriction of the arterioles of the nasal mucosa and conjunctiva.
-
It is used for the temporary relief in nasal and nasopharyngeal mucosal congestion in patients with allergic rhinitis.
Xylometazoline Dose in Adults
Dose in the treatment of Nasal congestion: Intranasal:
-
Drops (0.1%):
- 2 to 3 drops are applied drops in each nostril after every 8 to 10 hours
-
Metered-dose spray (0.1%):
- Single spray in each nostril after every 8 to 10 hours
-
Spray (0.05%, 0.1%):
- 1 or 2 sprays are given in each nostril after every 8 to 10 hours
Xylometazoline Dose in Children:
-
Infants and children 6 months to 12 years of age:
- 2 or 3 drops of 0.05% solution to nasal mucosa every 8 to 10 hours.
- The dose should not be repeated for more than three times in 24 hours.
-
Infants younger than age 6 months
- 1 drop of 0.05% solution in each nostril every six hours as needed under medical direction
Pregnancy Risk Factor: C
- According to the manufacturer it is not recommended for use during pregnancy.
Xylometazoline use during breastfeeding:
- It is unknown if xylometazoline excreted in breastmilk or not.
- The manufacturer recommends that nursing mothers not be given xylometazoline.
Xylometazoline dose in Renal Disease:
- No adjustment in the dose is necessary.
Xylometazoline Dose in Liver Disease:
- No adjustment in the dose is necessary.
Less Common Side Effects of Xylometazoline Include:
-
Central nervous system:
- Headache
-
Gastrointestinal:
- Nausea
-
Local:
- Application site burning
-
Respiratory:
- Dry nose
- Nasal discomfort
Contraindication to Xylometazoline Include:
- Allergy reactions to xylometazoline and any component of the formulation
- Patients who had to have transsphenoidal hypophysectomy (or surgery that exposed the dura mater) performed by a surgeon.
- Narrow-angle glaucoma
- Rhinitis sicca
- Atrophic rhinitis
Warnings and precautions
- Rebound your nasal congestion
- Nasal congestion can recur, or worsen, if it is prolonged or repeated.
- Cardiovascular disease
- Patients with heart disease or hypertension should be cautious.
- Diabetes mellitus:
- Patients with diabetes mellitus should be cautious.
- Thyroid disease:
- Patients with thyroid disease should be cautious.
- Prostatic hyperplasia/Urinary Obstruction:
- Patients with prostatic hyperplasia or GU obstruction should be cautious.
Xylometazoline (United States: Not available): Drug Interaction
|
Alpha1-Blockers |
May diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1Agonists may antagonize Alpha1-Blocker vasodilation. |
|
AtoMOXetine |
May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics. |
|
Cannabinoid-Containing Products |
May enhance the tachycardic effect of Sympathomimetics. Exceptions: Cannabidiol. |
|
Doxofylline |
Sympathomimetics may enhance the adverse/toxic effect of Doxofylline. |
|
FentaNYL |
|
|
Guanethidine |
May enhance the arrhythmogenic effect of Sympathomimetics. Guanethidine may enhance the hypertensive effect of Sympathomimetics. |
|
Solriamfetol |
Sympathomimetics may enhance the hypertensive effect of Solriamfetol. |
|
Sympathomimetics |
May enhance the adverse/toxic effect of other Sympathomimetics. |
|
Tricyclic Antidepressants |
May enhance the therapeutic effect of Alpha1-Agonists. Tricyclic Antidepressants may diminish the therapeutic effect of Alpha1-Agonists. |
|
Risk Factor D (Consider therapy modification) |
|
|
Cocaine (Topical) |
May enhance the hypertensive effect of Sympathomimetics. Management: Consider alternatives to use of this combination when possible. Monitor closely for substantially increased blood pressure or heart rate and for any evidence of myocardial ischemia with concurrent use. |
|
Esketamine |
|
|
Linezolid |
May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid. Specific dose adjustment recommendations are not presently available. |
|
Risk Factor X (Avoid combination) |
|
|
Ergot Derivatives |
May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists. Exceptions: Ergoloid Mesylates; Nicergoline. |
|
Iobenguane Radiopharmaceutical Products |
Alpha1-Agonists may diminish the therapeutic effect of Iobenguane Radiopharmaceutical Products. Management: Discontinue all drugs that may inhibit or interfere with catecholamine transport or uptake for at least 5 biological half-lives before iobenguane administration. Do not administer these drugs until at least 7 days after each iobenguane dose. |
|
Monoamine Oxidase Inhibitors |
May enhance the hypertensive effect of Alpha1-Agonists. While linezolid is expected to interact via this mechanism, management recommendations differ from other monoamine oxidase inhibitors. Refer to linezolid specific monographs for details. Exceptions: Linezolid; Tedizolid. |
|
Tedizolid |
May enhance the hypertensive effect of Sympathomimetics. Tedizolid may enhance the tachycardic effect of Sympathomimetics. |
Monitoring Parameters:
No monitoring parameters mentioned.
How to administer Xylometazoline?
For intranasal use only.
- First, blow nose to clear nostrils before using.
- Then tilt the head slightly forward (for spray) or backward (for drops)
- Then spray solution or apply drops into the affected nostril.
- After usage of spray or drops inhale deeply.
- Tip of the container should be wiped clean after each use.
- Some products are needed to be primed before initial use.
Mechanism of action of Xylometazoline:
- It stimulates the alpha-adrenergic receptors of the conjuntiva arterioles and the nasal mucosa, causing vasoconstriction
The nasal spray begins to work:
- It causes vasoconstriction in the local area within 2 minutes
Duration of action:
- It is up to 12 hours
International Brands of Xylometazoline:
- Af-Care
- Amidrin
- Antazol
- Balkis
- Cirovin
- Colirio Azul
- Decon
- Decozal
- Ezybreth
- Fastorik N
- FLO Rapid Relief
- Galazolin
- Gelonasal
- Hidropid
- Huma-Metazol
- Hysan
- Nasan
- NasenGel ratiopharm
- NasenSpray ratiopharm
- NasenTropfen ratiopharm
- Nasoferm
- Nasolin
- Nasostop
- Nazol N
- Neusdruppels
- Novin
- Novorin
- Olynth
- Osco Xuzulex Nasal Spray
- Otrinase
- Otriven
- Otrivin
- Otrivina
- Otrivine
- Pen Ke Tong
- Rhinidine
- Rhinozol
- Senziola
- Sinuvin
- Snup Stada
- Tezoline
- Tyzine
- Xoline
- Xylo-POS
- Xylolin
- Xylomaris
- Xylomet
- Xylovit
- Xymelin
- Balminil Decongest
- Otrivin
- Alpha-Adrenergic Agonist
- Decongestant
- Imidazoline Derivative
Xylometazoline Nasal Spray in Pakistan:
- Lyzo - Alina
- Nasavin - Cibex
- Rhezole - Epla
- Xlomet - Karachi chemical
- Xolisan - Sante
- Xylomed - Mediate
- Xylonas - Geofman
- Xynosine - Zafa
Xylometazoline (HCl) [Nasal Drops 5 ml] |
|
| Xlomet | Karachi Chemical Industries |
Xylometazoline (HCl) [Nasal Drops 0.05 %w/v] |
|
| Xlomet | Karachi Chemical Industries |
| Xynosine C.F | Zafa Pharmaceutical Laboratories (Pvt) Ltd. |
Xylometazoline (HCl) [Nasal Spray 0.1 %w/v] |
|
| Lyzo | Alina Combine Pharmaceuticals (Pvt) Ltd. |
| Xolisan | Sante (Pvt) Limited |
| Xylomed | Mediate Pharmaceuticals (Pvt) Ltd |
| Xylometazoline | Karachi Chemical Industries |
| Xylonas | Geofman Pharmaceuticals |
| Xynosine | Zafa Pharmaceutical Laboratories (Pvt) Ltd. |